| Market Capitalization (Millions $) |
147 |
| Shares
Outstanding (Millions) |
30 |
| Employees |
122 |
| Revenues (TTM) (Millions $) |
72 |
| Net Income (TTM) (Millions $) |
-36 |
| Cash Flow (TTM) (Millions $) |
-15 |
| Capital Exp. (TTM) (Millions $) |
2 |
Neuronetics Inc
Neuronetics Inc is a medical technology company that focuses on developing and commercializing non-invasive brain stimulation therapies for patients with psychiatric and neurological disorders. The company's flagship product is NeuroStar Advanced Therapy, which utilizes transcranial magnetic stimulation (TMS) to target specific areas of the brain involved in mood regulation.
NeuroStar Advanced Therapy is FDA-approved for the treatment of major depressive disorder (MDD) and is backed by clinical studies demonstrating its effectiveness. The procedure involves the use of a non-invasive device that delivers magnetic pulses to the brain, stimulating the nerve cells involved in mood regulation.
Neuronetics Inc is committed to providing alternative treatment options for patients who have not responded well to traditional therapies, such as medication or talk therapy. They aim to improve patients' quality of life by reducing symptoms of depression and other psychiatric disorders.
The company is based in Malvern, Pennsylvania, and collaborates with healthcare professionals, researchers, and patients to advance the understanding and adoption of TMS therapy. Neuronetics Inc is dedicated to ongoing research and development to expand the applications of TMS technology and improve patient outcomes in the field of mental health.
Company Address: 3222 Phoenixville Pike Malvern 19355 PA
Company Phone Number: 640-4202 Stock Exchange / Ticker: NASDAQ STIM
|
9.12%